Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Keith Dawson"'
Autor:
Ahmad S. Halwani, Kelli M. Rasmussen, Vikas Patil, Deborah Morreall, Catherine Li, Christina Yong, Zachary Burningham, Keith Dawson, Anthony Masaquel, Kevin Henderson, Elisha DeLong‐Sieg, Brian C. Sauer
Publikováno v:
Cancer Medicine, Vol 9, Iss 20, Pp 7537-7547 (2020)
Abstract Real‐world practice patterns and clinical outcomes in patients with follicular lymphoma (FL), including the adoption of maintenance rituximab (MR) therapy in the United States (US), have been reported in few studies since the release of th
Externí odkaz:
https://doaj.org/article/8499b8c9b6b045c18a609fd2d80fd1a5
Autor:
Aleksandar Sekulic, Simon Yoo, Ragini Kudchadkar, Julie Guillen, Gary Rogers, Anne Lynn S. Chang, Scott Guenthner, Bernard Raskin, Keith Dawson, Yong Mun, Laura Chu, Edward McKenna, Mario Lacouture
Publikováno v:
PLoS ONE, Vol 17, Iss 1 (2022)
Background Limited information is available regarding real-world treatment patterns and their effectiveness and safety in patients with locally advanced basal cell carcinoma, including patients not typically represented in clinical trials. The purpos
Externí odkaz:
https://doaj.org/article/17287a88382e40d780f87974d4f15a98
Autor:
Esther, Drill, Annie, Qiu, Sheila, Shapouri, Tu My, To, Arliene, Ravelo, Jake, Schade, Keith, Dawson, Matthew, Matasar
Publikováno v:
Oncology (Williston Park, N.Y.). 35(12)
INTRODUCTION: A subcutaneous (SC) formulation of the anti-CD20 monoclonal antibody, rituximab (Rituxan), is approved in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia (CLL). Rituximab-SC (R-SC) has b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::89d0cae7f531d117f72828b3a771de45
https://pubmed.ncbi.nlm.nih.gov/35089000
https://pubmed.ncbi.nlm.nih.gov/35089000
Autor:
Keith Dawson, Dane Callow, Jimmy Ngueyn, Altovise T. Ewing, Ruma Bhagat, William Boyd, Caroline McCammond, Nicole Richie
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 31:PO-195
Introduction Population-specific disparities in clinical research are well characterized-with individuals of European ancestry comprising the majority of genetic and clinical data globally. Disease course and treatment response can vary across indivi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ad03f4ff172b615c38f26c7029f4e3f
https://doi.org/10.1158/1538-7755.disp21-po-195
https://doi.org/10.1158/1538-7755.disp21-po-195
Autor:
C William, Hanke, Shivani K, Mhatre, David, Oliveri, Marko, Zivkovic, Ivor, Caro, Daniel, Bergström, Keith, Dawson, Camelia S, Sima
Publikováno v:
Journal of drugs in dermatology : JDD. 17(2)
Information is limited on the use of vismodegib for treatment of advanced basal cell carcinoma beyond the setting of clinical trials.To investigate the treatment patterns and characteristics of patients treated with vismodegib in clinical practice.A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3bfef72a293329018e3120a7c259bfc2
https://pubmed.ncbi.nlm.nih.gov/29462221
https://pubmed.ncbi.nlm.nih.gov/29462221
Autor:
Keith Dawson
Publikováno v:
Journal of Infusion Nursing. 36:172-178
The majority of follicular non-Hodgkin's lymphoma patients in the United States receive an initial treatment strategy that includes the infusion of rituximab. Data from a phase III multicenter clinical trial led to the 2012 US Food and Drug Administr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5f410c6bef1581feaffb48454ab77b
https://doi.org/10.1097/nan.0b013e318288a103
https://doi.org/10.1097/nan.0b013e318288a103
Autor:
Keith Dawson
Need to know how to buy a phone switch for your call center? How to measure the productivity of agents? How to choose from two cities that both want your center? No problem. The Call Center Handbook is a complete guide to starting, running, and im
Autor:
Susan J. Little, W. Christopher Mathews, Eric S. Daar, Simon D. W. Frost, Douglas D. Richman, Keith Dawson, Andrew J. Leigh Brown, Nicholas S. Hellmann
Publikováno v:
The Journal of Infectious Diseases. 187:683-686
Although the prevalence of drug-resistant strains in primary human immunodeficiency virus (HIV) infection in North America has recently increased, their transmission fitness remains unknown. The present study estimated the frequency of transmission o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39dbac5948be12f403da2547114b9c4
https://doi.org/10.1086/367989
https://doi.org/10.1086/367989
Publikováno v:
Neuropsychological Rehabilitation. 11:529-537
EuroQol-5D has been used as a means of assessing health service effectiveness. This study examines its validity regarding people with acquired neurological disorders. Fifty-two participants with such disorders were studied. Each person completed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::612ded0b39f017b5fb2a53816b40abe3
https://doi.org/10.1080/09602010042000231
https://doi.org/10.1080/09602010042000231
Publikováno v:
Neuropsychological Rehabilitation. 9:385-400
The Kemsley Division has been providing a specialised service for people with acquired neurological damage and challenging behaviour problems for over two decades. This paper reviews some of the methods used to evaluate behavioural outcome. After a b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e97457faf5d21f80a15b91f99f7a1c18
https://doi.org/10.1080/096020199389455
https://doi.org/10.1080/096020199389455